Iodine crosses the placental barrier. Clinical experience of use in pregnant women is limited. Insufficient animal data are available. Cadexomer iodine should therefore not be used in pregnant or lactating women.
Iodine is secreted into breast milk. Cadexomer iodine should not be used in lactating women.
It is unlikely to have an effect.
About 5% of the patients treated with cadexomer iodine experience a transient smarting or pain within the first hour after application. Contact allergy, alteration in thyroid function and local oedema have been reported in rare cases. Minor reddening or swelling around the wound may occur without necessarily being an allergic reaction.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
